Objectives

The JA Stockpile aims to contribute to better preparedness in case of serious cross-border threats. Its goal is to prepare countries to have more sustainable stockpiles of Medical Countermeasures (MCMs) to enhance faster distribution, better deployment and dispensing of MCMs, better collaboration between member states, better evidence base for future proposals on stockpiling of MCMs, thus strengthening European independence in crisis situations. Stockpile is active for three years until June 2028.  

Consortium

The JA Stockpile project brings together 54 organisations from 25 EU European Union (European Union) countries, alongside key authorities such as HERA, European Centre for Disease Prevention and Control (ECDC), European Medicines Agency, ECHO, and WHO. With this coordinated effort, we take an important step forward in building resilient European health systems, capable of responding more effectively to future emergencies.

RIVM role

RIVM has a leading role in work package 6: Identifying and quantifying stockpiles for medical countermeasures.  In addition, RIVM contributes to other work packages with activities aimed at sustainable stockpile management and at removing logistical and legal barriers to ensure that medical countermeasures can be deployed effectively in times of crisis.

Funding

JA Stockpile  is funded by the European Union and implemented under the EU4Health Programme (2021-2027).